The importance of these cytokines in the pathogenesis of CRSwNP is strengthened by the dramatic clinical responses to dupilumab, a fully humanized monoclonal antibody blocking IL-4Rα. Here, IL4R is linked to chronic rhinosinusitis with nasal polyps.